ArticleiScience2026
MORC1 coordinates TRIM28 interaction and nuclear condensate formation for transposon silencing.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MORC1-mediated transposon repression involves DNA methylation and H3K9me3 deposition, yet the underlying mechanism remains unclear. Here, we show that MORC1 assembles discrete nuclear bodies in gonocytes and, using a doxycycline-inducible NIH3T3 cell system, define two properties: MORC1 drives nuclear condensate formation through an intrinsically disordered region (IDR) containing a bipartite nuclear localization signal, and MORC1 binds TRIM28, a corepressor that recruits the H3K9 methyltransferase SETDB1, and concentrates it within these bodies through protein-protein interactions. An IDR-deficient MORC1 mutant fails to form nuclear condensates but retains TRIM28 binding. Chromatin immunoprecipitation sequencing (ChIP-seq) reveals that this mutant occupies heterochromatin-embedded transposons more strongly than wild-type MORC1, particularly evolutionarily young subfamilies overlapping endogenous MORC1 targets. Notably, exogenous MORC1 forms substantially larger condensates than endogenous MORC1 in gonocytes, and fluorescence recovery after photobleaching (FRAP) analysis shows that MORC1 condensates limit diffusion. We propose a model in which MORC1 function is shaped by coordinated TRIM28 interaction and quantitatively restrained, IDR-dependent condensate formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.